Physician profile
Gregory S Thomas
NPI 1407834146
$20,834.38
in general payments reported to CMS, 2019-2025
11 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,900 · 2022: $196 · 2024: $322 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19,243.08 | 2019-2020 | |
| Elutia, INC. | $295.79 | 2019 | |
| Boston Scientific Corporation | $274.54 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $237.39 | 2024-2025 | |
| Pfizer INC. | $219.78 | 2019-2024 | |
| Amgen INC. | $219.61 | 2019 | |
| Philips North America LLC | $150.00 | 2025 | Ecc Solutions |
| Atricure, INC. | $79.96 | 2024-2025 | Synergy Ablation System |
| Alnylam Pharmaceuticals INC. | $73.20 | 2024 | Amvuttra |
| Abbott Laboratories | $22.32 | 2024 | Cardiomems |
| Irhythm Technologies, INC. | $18.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.